Loading clinical trials...
Loading clinical trials...
Biomarker Signature-Supported Antibiotic Treatment Decisions in Intensive Care Units
Conditions
Interventions
Biomarker-signature supported antibiotic treatment recommendation
Clinical assessment for antibiotic treatment decision
Locations
4
Canada
Montreal General Hospital
Montreal, Quebec, Canada
Research Institute of McGill University Health Center (RI-MUHC)
Montreal, Quebec, Canada
Royal Victoria Hospital
Montreal, Quebec, Canada
Research Institute McGill University Health Centre
Montreal, Quebec, Canada
Start Date
May 13, 2025
Primary Completion Date
May 1, 2028
Completion Date
August 1, 2028
Last Updated
March 19, 2026
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions